Translational fMRI: Bridging Neuroscience, Medicine, and Clinical Practice.

Functional Magnetic Resonance Imaging (fMRI), particularly blood-oxygen-level-dependent (BOLD) contrast fMRI, measures physiological changes in blood oxygenation related to neural activity. Originally a foundational tool in cognitive neuroscience, fMRI is translating into clinical practice, neurosurgery, and drug development.

​Key Applications

1.Pre-surgical and Functional Neurosurgical Planning

• Functional Mapping: fMRI identifies the critical motor, sensory and language regions near the lesions and helps to spare the critical tissues during resection.

• Multimodal Integration: Integration of fMRI with diffusion MRI (dMRI) can be used to visualize white matter pathways in addition to functional cortices.

• Targeting Interventions: fMRI helps to identify brain regions to be targeted for ablation or deep brain stimulation (DBS) electrode placement.

2.Spontaneous Activity & Epilepsy Mapping

• EEG-fMRI: Simultaneous acquisition of EEG and fMRI can be used to map the neural generators of spontaneous epileptiform activity which can help to localize surgical foci in patients with complex partial or generalized seizures.

• Symptom Dynamics: fMRI can monitor spontaneous physiological changes, like the development of a migraine aura (a set of sensory, visual, or speech symptoms that act as a warning sign before a neurological event, most commonly a migraine attack or an epileptic seizure)

3.Disease Characterization & Intermediate Phenotypes

• Neuropsychiatric Subtyping: fMRI provides a tool to detect intermediate phenotypes and endophenotypes, quantifiable biological traits that bridge the gap between genetic polymorphisms and the complex psychiatric disorders, such as schizophrenia and depression.

• Imaging Genomics: BOLD responses are quantitative traits that can be scored using smaller sample sizes than the traditional genetic association studies to evaluate candidate genes (e.g., COMT, GRM3, DISC1 and SLC6A4).

4.Pharmacological fMRI (phMRI)

• Drug Action & Biomarkers: phMRI assesses pharmacodynamics and pharmacokinetics by measuring the direct activation of the brain or changes in the brain as a result of a drug during probe tasks.

• PhMRI can be used in combination with positron emission tomography (PET) to help validate targets, determine optimal doses in studies and to identify potential responders to treatment in early clinical trials.

5.Functional Plasticity and Neurorehabilitation

• Brain Reorganization: Using fMRI to understand adaptive functional changes after brain injury, stroke, or neurodegenerative diseases (e.g., multiple sclerosis).

• Outcome Prediction: Early measures of functional activation patterns can be used to stratify patients for targeted rehabilitation programs and to measure the effectiveness of trials.

Future Perspectives & Methodological Horizons

Real-Time fMRI (rt-fMRI): Computational advances make it possible to monitor fMRI quality in real time and to optimally adjust the protocol during the scan.

Resting-State Networks (RSNs): Low-frequency BOLD fluctuations during rest removes task-performance demands for severely impaired patients, and have the potential to reveal intrinsic network disruptions, e.g., in Alzheimer's disease.

Alternative MRI contrast methods such as Arterial Spin Labeling (ASL) have the advantage of a higher stability for monitoring slow physiological changes over time and quantification of the cerebral metabolic rate of oxygen consumption CMRO2 .

Hybrid Imaging Modalities: The use of fMRI with simultaneous PET hardware or low cost portable technologies such as Near-Infrared Spectroscopy (NIRS) will complement the relationship between molecular mechanisms, cortical activation and bed-side clinical monitoring.

Source: ​Matthews, P. M., Honey, G. D., & Bullmore, E. T. (2006). Applications of fMRI in translational medicine and clinical practice. Nature Reviews Neuroscience, 7(9), 732–744.